Translate
Tenax Therapeutics Inc
About
Tenax Therapeutics Inc (NASDAQ:TENX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
Mar 10 2026
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 3 2026
Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference
Feb 4 2026
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026
Dec 17 2025
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
Financials
Revenue
$0
Market Cap
$258.22 M
EPS
-1.34